Koyfin Home > Directory > Health Care > Amphastar Pharma > Return on Capital %

Amphastar Pharma Return on Capital % Chart (AMPH)

Amphastar Pharma annual/quarterly Return on Capital % from 2014 to 2018.
  • Amphastar Pharma Return on Capital % for the quarter ending December 12, 2018 was 0.96 a 742.79% increase of 7.11 year over year
  • Amphastar Pharma Return on Capital % for the last 12 months ending December 12, 2018 was -1.35 a -46.52% increase of 0.63 year over year
  • Amphastar Pharma Annual Return on Capital % for 2018 was -1.35 a 56.06% decrease of -0.76 from 2017
  • Amphastar Pharma Annual Return on Capital % for 2017 was -0.59 a 582.35% decrease of -3.45 from 2016
  • Amphastar Pharma Annual Return on Capital % for 2016 was 2.86 a 123.76% increase of 3.54 from 2015
Other Margins & Efficiency Metrics:
  • Amphastar Pharma EBITDA Margin for the quarter ending December 12, 2018 was $6m a 248.20% increase of 16m year over year
  • Amphastar Pharma Return on Equity % for the quarter ending December 12, 2018 was 1.95 a 547.96% increase of 10.67 year over year
View Chart On Koyfin

Quarterly AMPH Return on Capital % Data

12/20180.96
09/20181.67
06/2018-1.82
03/2018-6.15
12/2017-1.09
09/2017-1.94
06/20171.47
03/2017-0.85
12/2016-3.05
09/20164.02

Annual AMPH Return on Capital % Data

2018-1.35
2017-0.59
20162.86
2015-0.68
2014-3.69
20133.97